Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Arat"'
Autor:
I‐Hung Shao, Hsiang‐Shen Wang, Chin‐Hsuan Hsieh, Tsung‐Lin Lee, Ying‐Hsu Chang, Liang‐Kang Huang, Yuan‐Cheng Chu, Hung‐Chen Kan, Po‐Hung Lin, Kai‐Jie Yu, Chun‐Te Wu, Cheng‐Keng Chuang, See‐Tong Pang
Publikováno v:
Cancer Medicine, Vol 13, Iss 21, Pp n/a-n/a (2024)
ABSTRACT Background This study aimed to identify the clinical predictors for the response of patients with mCRPC to ARATs. Materials and Methods We retrospectively collected data on consecutive patients who were diagnosed with mCRPC and underwent ARA
Externí odkaz:
https://doaj.org/article/2e7066fa5e1b493097b1b7e05e3df66d
Autor:
Milyausha R. Gaynanova
Publikováno v:
Историческая этнология, Vol 9, Iss 1, Pp 112-121 (2024)
The article analyses a letter by Rabiga Arat addressed to her husband, the famous scholar, Turkologist, Rashit Rahmati Arat. In the submitted document, Rabiga khanum writes about family news and the life of the Tatar emigrant community. This document
Externí odkaz:
https://doaj.org/article/6a554f12251f43d983b8747db7993a7f
Publikováno v:
Current Oncology, Vol 31, Iss 2, Pp 1047-1062 (2024)
Prostate cancer accounts for a significant proportion of cancer diagnoses in Canadian men. Over the past decade, the therapeutic landscape for the management of metastatic prostate cancer has undergone rapid changes. Novel strategies use hormonal age
Externí odkaz:
https://doaj.org/article/13eff17c379d43649d82cccbf7ff4f17
Publikováno v:
SeeNews Research & Profiles (Company Profiles). 2015, p320-325. 6p.
Publikováno v:
SeeNews Research & Profiles (Company Profiles). 2013, p1006-1011. 6p.
Publikováno v:
IEEE Transactions on Neural Systems and Rehabilitation Engineering, Vol 32, Pp 3157-3166 (2024)
The evidence-based quantification of the relation between changes in movement quality and functionality can assist clinicians in achieving more effective structuring or adapting of therapy. In this paper, clinicians rated task, segment, and composite
Externí odkaz:
https://doaj.org/article/b6c7cff6cb104a6f96d25d3230cae159
Publikováno v:
SeeNews Research & Profiles (Company Profiles). 2012, p502-507. 5p.
Publikováno v:
SeeNews Research & Profiles (Company Profiles). 2011, Special section p1-6. 6p.
Autor:
Saizo Fujmoto, Kazutoshi Fujita, Mitsuhisa Nishimoto, Mamoru Hamaguchi, Ken Kuwahara, Mamoru Hashimoto, Shogo Adomi, Takafumi Minami, Masahiro Nozawa, Kazuhiro Yoshimura, Hirotsugu Uemura
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3176-3179 (2023)
Abstract Enzalutamide, apalutamide, and darolutamide are currently recommended for patients with non‐metastatic castration‐resistant prostate cancer (nmCRPC), but cross‐resistance of androgen receptor‐axis‐targeted therapies (ARAT) occurs.
Externí odkaz:
https://doaj.org/article/f9ff1f67dce24f7fabefde0baaee780d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.